查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1939273

2026年全球氧合器市场报告

Artificial Lung Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，氧合器市场发展迅速，预计将从2025年的25.8亿美元成长到2026年的28.8亿美元，复合年增长率达11.6%。过去几年的成长归因于多种因素，例如急性呼吸衰竭病例的增加、心胸外科手术中体外循环技术的早期应用、器官移植数量的增加、膜氧合技术的发展以及体外生命支持的日益普及。

预计未来几年人工肺市场将快速成长，到2030年市场规模将达到42.7亿美元，复合年增长率（CAGR）为10.4%。预测期内的成长要素包括：对重症监护生命支持的需求不断增长；对携带式和小型人工肺系统的关注度日益提高；对先进氧合膜材料的投资不断增加；在急诊和创伤护理领域的应用不断扩展；以及微创体外支持解决方案的日益普及。预测期内的主要趋势包括：严重呼吸衰竭和重症监护管理领域对人工肺系统的需求不断增长；复杂心臟和肺移植手术中体外支持设备的广泛应用；微创和临时性肺支持作为移植的替代方案越来越受到青睐；用于急诊护理的携带式和可运输人工肺装置不断发展；以及基于膜的人工肺技术在高效气体应用和长期支持方面的广泛发展。

预计未来几年呼吸系统疾病盛行率的上升将推动人工肺市场的成长。空气污染加剧、气候变迁和生活方式改变等因素加剧了呼吸系统疾病带来的公共卫生负担。人工肺透过向血液输送氧气和清除二氧化碳来补充或取代受损的肺功能。例如，根据澳洲健康与福利研究所 (AIHW) 估计，截至 2024 年 6 月，约有 850 万澳洲人（占总人口的 34%）将患有慢性呼吸系统疾病。其中，约有 280 万人（占总人口的 11%）将患有气喘，63.8 万人（占总人口的 2.5%）将患有慢性阻塞性肺病(COPD)。呼吸系统疾病盛行率的上升趋势正在推动人工肺市场的成长。

人工肺市场的主要企业正致力于开发携带式体外膜氧合（ECMO）系统等先进解决方案，旨在使体外生命支持能够应用于加护病房（ICU）以外的领域，加快患者转运速度，并方便现场部署。携带式气动ECMO系统采用氧气供应驱动帮浦和整合气体管理技术，无需外部电源或大型电气元件即可提供体外氧合和循环支援。例如，2024年5月，德国医疗设备製造商Hemovent GmbH宣布，其全球首款整合式便携式气动ECMO系统MOBYBOX在欧洲首次投入商业性应用。 MOBYBOX重量约2.5公斤，仅依靠氧气供应即可运行，无需电池或马达。它采用Bionique Flow技术，可实现更温和的血液处理并提高气体交换效率，并已获得医疗设备法规（MDR）认证，可率先进入市场。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球氧合器市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 严重呼吸衰竭和重症监护管理中对人工肺系统的需求不断增长
    • 体外辅助装置在复杂心臟和肺部移植手术的应用日益增多
    • 微创临时肺部支持技术正日益被用作肺移植的替代方案。
    • 加快开发用于紧急医疗环境的携带式、可运输式氧合器装置
    • 扩大膜式人工肺技术的应用，以实现高效气体交换和长期支持

第五章 终端用户产业市场分析

  • 医院
  • 急诊中心
  • 专业心臟外科中心
  • 移植护理单元
  • 其他最终用户

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球氧合器市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球氧合器市场规模、比较及成长率分析
  • 全球氧合器市场表现：规模与成长，2020-2025年
  • 全球氧合器市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 单滚轮泵体外循环机、双滚轮泵体外循环机、鼓泡式氧合器、膜式氧合器
  • 透过使用
  • 心臟手术、肺移植手术、急性呼吸衰竭的治疗等用途
  • 最终用户
  • 医院、急诊中心和其他最终用户
  • 按类型细分：单滚轮泵体外循环机
  • 携带式式单滚轮帮浦体外循环机，固定式单滚轮帮浦体外循环机
  • 依类型细分：双滚轮帮浦体外循环机
  • 携带式双滚轮帮浦体外循环机，固定式双滚轮帮浦体外循环机
  • 依类型细分：鼓泡式增氧机
  • 抛弃式气泡式氧气机，可重复使用气泡式氧气机
  • 按类型细分：膜式氧合器
  • 膜式氧合器，二氧化碳去除膜式氧合器

第十章 区域与国家分析

  • 全球氧合器市场：按地区、性能和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球氧合器市场：按国家、性能和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 氧合器市场：竞争格局及市场占有率（2024年）
  • 氧合器市场：公司估值矩阵
  • 氧合肺市场：公司简介
    • Getinge AB
    • Medtronic plc
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care AG & Co KGaA

第37章：其他领先和创新企业

  • ALung Technologies Inc, Xenios AG, Eurosets Srl, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年氧合器市场：提供新机会的国家
  • 2030年氧合器市场：充满新机会的细分市场
  • 2030年氧合器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MALUN01_G26Q1

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

Tariffs are influencing the artificial lung market by increasing the cost of imported precision components, membranes, pumps, and control electronics used in heart-lung machines and membrane artificial lung systems, thereby raising overall production and procurement costs for hospitals and emergency care facilities. The most affected segments include membrane artificial lung devices and portable roller pump systems, particularly in regions dependent on international sourcing such as Asia-Pacific and Europe. At the same time, tariffs are encouraging near-shore manufacturing, regional assembly, and supplier diversification, which may support innovation and strengthen supply resilience in the long term across artificial lung product segments.

The artificial lung market research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including artificial lung industry global market size, regional shares, competitors with a artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.58 billion in 2025 to $2.88 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in incidence of acute respiratory failure cases, early adoption of heart lung machines in cardiothoracic surgery, growth in organ transplant procedure volumes, development of membrane artificial lung technology, increasing utilization of extracorporeal life support systems.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for critical care life-support devices, growing focus on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, expansion of applications in emergency and trauma care, increasing adoption of minimally invasive extracorporeal support solutions. Major trends in the forecast period include increasing demand for artificial lung systems in severe respiratory failure and critical care management, rising adoption of extracorporeal support devices in complex cardiac and lung transplant surgeries, growing preference for minimally invasive and temporary lung support alternatives to transplantation, increasing development of portable and transport-compatible artificial lung units for emergency care settings, expanding use of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

The rising prevalence of respiratory diseases is expected to drive growth in the artificial lung market in the coming years. Factors such as increasing air pollution, climate change, and lifestyle changes have contributed to a growing burden of respiratory conditions on public health. Artificial lungs are employed to support or replace impaired lung function by providing oxygenation and removing carbon dioxide from the blood. For example, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million Australians, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people (11% of the population) living with asthma and 638,000 people (2.5% of the population) living with chronic obstructive pulmonary disease (COPD). As a result, the growing prevalence of respiratory diseases is propelling the artificial lung market forward.

Major companies operating in the artificial lung market are focusing on developing advanced solutions, such as portable pneumatic ECMO systems, to extend extracorporeal life support beyond the ICU and facilitate rapid patient transport and field deployment. Portable pneumatic ECMO systems use oxygen-supply-driven pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without dependence on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, the world's first integrated portable pneumatic ECMO system, completed its initial commercial applications in Europe. MOBYBOX weighs approximately 2.5 kg, operates solely on oxygen supply without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and enhanced gas exchange, and has obtained Medical Device Regulation certification for its initial markets.

In August 2024, Getinge AB, a Sweden-based medical technology company, acquired Paragonix Technologies for approximately US$477 million. This acquisition is intended to expand Getinge's organ preservation and transplant logistics portfolio by integrating Paragonix's advanced organ transport and storage systems, thereby improving transplant outcomes and strengthening Getinge's position in cardiac and thoracic transplant workflows. Paragonix Technologies is a US-based company specializing in organ preservation and transport solutions for cardiac and thoracic transplantation.

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
  • 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
  • 3) By End-Users: Hospital; Emergency Center; Other End-users
  • Subsegments:
  • 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
  • 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
  • 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
  • 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
  • Companies Mentioned: Getinge AB; Medtronic plc; LivaNova PLC; Terumo Corporation; Fresenius Medical Care AG & Co KGaA; ALung Technologies Inc; Xenios AG; Eurosets S.r.l; Nipro Corporation; Braile Biomedica; Hemovent GmbH; MC3 Cardiopulmonary Inc; Abbott Laboratories; Spectrum Medical Ltd; B Braun Melsungen AG; SB-Kawasumi Laboratories Inc; Senko Medical Instrument Mfg Co Ltd; CARMAT; Technowood International Pte Ltd; Elite Lifecare; Cytosorbents Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Lung Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Lung Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Lung Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Lung Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Demand For Artificial Lung Systems In Severe Respiratory Failure And Critical Care Management
    • 4.2.2 Rising Adoption Of Extracorporeal Support Devices In Complex Cardiac And Lung Transplant Surgeries
    • 4.2.3 Growing Preference For Minimally Invasive And Temporary Lung Support Alternatives To Transplantation
    • 4.2.4 Increasing Development Of Portable And Transport-Compatible Artificial Lung Units For Emergency Care Settings
    • 4.2.5 Expanding Use Of Membrane-Based Artificial Lung Technologies For Efficient Gas Exchange And Long-Term Support

5. Artificial Lung Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Emergency Centers
  • 5.3 Specialized Cardiac Surgery Centers
  • 5.4 Transplant Care Units
  • 5.5 Other End Users

6. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Lung Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Lung Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Lung Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Lung Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Lung Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Lung Market Segmentation

  • 9.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
  • 9.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
  • 9.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Emergency Center, Other End-users
  • 9.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
  • 9.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
  • 9.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
  • 9.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

10. Artificial Lung Market Regional And Country Analysis

  • 10.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Lung Market

  • 11.1. Asia-Pacific Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Lung Market

  • 12.1. China Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Lung Market

  • 13.1. India Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Lung Market

  • 14.1. Japan Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Lung Market

  • 15.1. Australia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Lung Market

  • 16.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Lung Market

  • 17.1. South Korea Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Lung Market

  • 18.1. Taiwan Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Lung Market

  • 19.1. South East Asia Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Lung Market

  • 20.1. Western Europe Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Lung Market

  • 21.1. UK Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Lung Market

  • 22.1. Germany Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Lung Market

  • 23.1. France Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Lung Market

  • 24.1. Italy Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Lung Market

  • 25.1. Spain Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Lung Market

  • 26.1. Eastern Europe Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Lung Market

  • 27.1. Russia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Lung Market

  • 28.1. North America Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Lung Market

  • 29.1. USA Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Lung Market

  • 30.1. Canada Artificial Lung Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Lung Market

  • 31.1. South America Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Lung Market

  • 32.1. Brazil Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Lung Market

  • 33.1. Middle East Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Lung Market

  • 34.1. Africa Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Lung Market Regulatory and Investment Landscape

36. Artificial Lung Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Lung Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Lung Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Lung Market Company Profiles
    • 36.3.1. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Fresenius Medical Care AG & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Lung Market Other Major And Innovative Companies

  • ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare

38. Global Artificial Lung Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Lung Market

40. Artificial Lung Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Lung Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Lung Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Lung Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer